The Market

Despite the technological advancements in treating AIDS over the past 20 years, there are still nearly 56,000 newly diagnosed HIV patients each year in the US. The majority of these people were infected by others unaware of their positive HIV status. Governments everywhere call for aggressive testing to identify and treat those infected. The CDC and the American College of Physicians now recommend routine testing for everyone ages 13 – 64 in the US.

Once considered a probable death sentence, long-term survival is now possible with early detection and early treatment. This change, along with increased testing opportunities using better, faster diagnostic technology, has lessened apprehension and encouraged people to test.

New market data shows that increased STDs drive the demand for rapid testing in the U.S. and around the world. The HIV testing market will exceed $3.9 billion by 2015, according to the new report by Global Industry Analysts. Beyond that, the FDA’s consideration of HIV rapid tests for home use remains forefront in the news. As does the concern of the healthy, sexually active population, to remain healthy through testing potential partners.

It adds up to a demand for an inexpensive, accurate, globally available, easy-to-use rapid test. Clarity Dx, with it’s advanced First Step© rapid test is poised to meet and exceed that need.

Please contact us for further information.